Comparison between the effect of oral chloral hydrate and intranasal dexmedetomidine on pediatric sedation for EEG

Comparison between the effect of oral chloral hydrate and intranasal dexmedetomidine on pediatric sedation for EEG in Isfahan Imam Hossein Hospital, in 2017

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180520039739N3

Enrollment

Registered

2019-04-22

Start date

2018-04-21

Completion date

Unknown

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedation.

Interventions

Intervention 1: Intervention group: Treatment with 50 mg/kg chloral hydrate 10% ( Kimia teb pajohan gharb)30 minute before EEG. Intervention 2: Intervention group: Treatment with 2 micro/kg dexmedetom

Eligibility

Sex/Gender

All

Age

3 Months to 3 Years

Inclusion criteria

Inclusion criteria: Patients with age of 3 month to 3 years Patients who need EEG patients with ASA1,ASA2

Exclusion criteria

Exclusion criteria: Sensitivity to dexmedetomidine or chloral hydrate in past medical histoty

Design outcomes

Primary

Measure	Time frame
Sedation. Timepoint: In One houre. Method of measurement: Ramsy score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza habibzadeh

Esfahan University of Medical Sciences

Gsmhabibzadeh@yahoo.com+98 31 3532 0551

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026